TABLE 7.2.

Results of clinical trials involving gatifloxacin

Author (reference)	Design	n ()	Indication	Regimen	Duration	Results
Genitourinary tract infections
Suzuki K et al (190) (Abst)	Noncomparative, open	11 (11)	Chronic bacterial prostatitis	Gatifloxacin: 200 mg oral bid	14 days	Overall clinical efficacy*: Gatifloxacin 10/11 (91%) Two to four week follow-up: relapse rate 3/9 (33%)

n () is the number of patients (number of patients with complete data at the end of treatment or at follow-up if there was no evaluation at the end of treatment).

^*Efficacy determined as ‘good’ or ‘excellent’ by the clinical investigator. Duration Length of treatment